Harmonia MentisHarmonia Mentis

The clinical experience with ONTOZRY®▼ - Questions with Professor Gregory Krauss

  1. Home
  2. UK HCP
  3. ONTOZRY®▼ (cenobamate)
    On Demand

  4. You are here: The clinical experience with ONTOZRY®▼ - Questions with Professor Gregory Krauss

Article

This webpage is intended for UK-I healthcare professionals.

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events and product complaint should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. Adverse events and product complaint should also be reported to Angelini Pharma on (UK) +44 2034889643, (IRE) +353 1 584 4671 or UKIReporting@angelinipharma.com

ⓘ Click here for Prescribing Information and Adverse Event Reporting

The clinical experience with ONTOZRY® - Questions with Professor Gregory Krauss

Here Professor Gregory Krauss answer a range of questions about his experience with using ONTOZRY® in a clinical setting.

UK22980P | April 2024

UK23588P | June 2024

;